RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $134,277 | -31.0% | 124,331 | -17.6% | 0.00% | -100.0% |
Q2 2023 | $194,547 | -68.9% | 150,812 | -68.1% | 0.00% | -66.7% |
Q1 2023 | $624,843 | -8.1% | 473,366 | -17.9% | 0.00% | -25.0% |
Q3 2022 | $680,000 | +103.0% | 576,606 | +414.8% | 0.00% | +33.3% |
Q1 2022 | $335,000 | +23.2% | 112,005 | +8.9% | 0.00% | +50.0% |
Q4 2021 | $272,000 | -32.8% | 102,816 | -7.7% | 0.00% | -60.0% |
Q3 2021 | $405,000 | +382.1% | 111,449 | +475.3% | 0.01% | +400.0% |
Q2 2021 | $84,000 | -73.1% | 19,373 | -78.8% | 0.00% | -80.0% |
Q1 2021 | $312,000 | +115.2% | 91,185 | +120.1% | 0.01% | +150.0% |
Q4 2020 | $145,000 | – | 41,438 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |